Jci_page_head_homepage_01 Jci_page_head_homepage_02
Juan Xicohtencatl-Cortes, Valério Monteiro-Neto, Maria A. Ledesma, Dianna M. Jordan, Olivera Francetic, James B. Kaper, José Luis Puente, Jorge A. Girón
Published in Volume 117, Issue 11
J Clin Invest. 2007; 117(11):3519–3529 doi:10.1172/JCI30727
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 2
Purification, biochemical analysis, and reactivity of HCP with sera from HUS patients.

(A) TEM micrograph showing bundles of long pili purified from EDL933. (B) Depolymerization of purified pili in 16% SDS-PAGE gels (MS, mass standards). The 19-kDa protein corresponds to the structural type IV HcpA pilin subunit. The purified pili were reacted with rabbit anti-PpdDK-12 antibody, a pool of human sera from HUS cases, and normal human (NH) sera. Note the reactivity of the pilin subunit with HUS sera and not with NH sera. (C) Specific immunogold labeling of HCP produced by EHEC EDL933 with anti-HCP antibody.